Literature DB >> 26447969

Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion.

Martin H Floch1, W Allan Walker, Mary Ellen Sanders, Max Nieuwdorp, Adam S Kim, David A Brenner, Amir A Qamar, Tamir A Miloh, Alfredo Guarino, Mario Guslandi, Levinus A Dieleman, Yehuda Ringel, Eamonn M M Quigley, Lawrence J Brandt.   

Abstract

This paper describes the consensus opinion of the participants in the 4th Triennial Yale/Harvard Workshop on Probiotic Recommendations. The recommendations update those of the first 3 meetings that were published in 2006, 2008, and 2011. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome and Clostridium difficile diarrhea are reviewed. In addition, we have added recommendations for liver disease for the first time. As in previous publications, the recommendations are given as A, B, or C ratings.

Entities:  

Mesh:

Year:  2015        PMID: 26447969     DOI: 10.1097/MCG.0000000000000420

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  25 in total

Review 1.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

2.  Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.

Authors:  Tamar Ringel-Kulka; Johnson McRorie; Yehuda Ringel
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

Review 3.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

Review 4.  Recent Advances in Prevention and Therapies for Clinical or Experimental Necrotizing Enterocolitis.

Authors:  Kewei Wang; Guozhong Tao; Karl G Sylvester
Journal:  Dig Dis Sci       Date:  2019-04-15       Impact factor: 3.199

Review 5.  Probiotics for the prevention of Hirschsprung-associated enterocolitis.

Authors:  Fan Mei; Mei Wu; Li Zhao; Kaiyan Hu; Qianqian Gao; Fei Chen; Joey Sw Kwong; Yanan Wang; Xi Ping Shen; Bin Ma
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

Review 6.  Intestinal Lactobacillus in health and disease, a driver or just along for the ride?

Authors:  Dustin D Heeney; Mélanie G Gareau; Maria L Marco
Journal:  Curr Opin Biotechnol       Date:  2017-09-01       Impact factor: 9.740

Review 7.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

8.  Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.

Authors:  Shelby R Hayes; Ashley J Vargas
Journal:  Explore (NY)       Date:  2016-08-26       Impact factor: 1.775

Review 9.  Microbiome and metabolome data integration provides insight into health and disease.

Authors:  Michael Shaffer; Abigail J S Armstrong; Vanessa V Phelan; Nichole Reisdorph; Catherine A Lozupone
Journal:  Transl Res       Date:  2017-07-14       Impact factor: 7.012

10.  Probiotics for treating acute infectious diarrhoea.

Authors:  Shelui Collinson; Andrew Deans; April Padua-Zamora; Germana V Gregorio; Chao Li; Leonila F Dans; Stephen J Allen
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.